Previous studies revealed a significant production of inflammatory cytokines together with severe thymic atrophy and thymocyte migratory disturbances during experimental Chagas disease. Migratory activity of thymocytes and mature T cells seem to be finely tuned by cytokines, chemokines and extracellular matrix (ECM) components. Systemic TNF-α is enhanced during infection and appears to be crucial in the response against the parasite. However, it also seems to be involved in disease pathology, since it is implicated in the arrival of T cells to effector sites, including the myocardium. Herein, we analyzed the role of TNF-α in the migratory activity of thymocytes in Trypanosoma cruzi (T. cruzi) acutely-infected mice. We found increased expression and deposition of TNF-α in the thymus of infected animals compared to controls, accompanied by increased co-localization of fibronectin, a cell migration-related ECM molecule, whose contents in the thymus of infected mice is also augmented. In-vivo studies showed an enhanced export of thymocytes in T. cruzi-infected mice, as ascertained by intrathymic injection of FITC alone or in combination with TNF-α. The increase of immature CD4+CD8+ T cells in secondary lymphoid organs was even more clear-cut when TNF-α was co-injected with FITC. Ex-vivo transmigration assays also revealed higher number of migrating cells when TNF-α was added onto fibronectin lattices, with higher input of all thymocyte subsets, including immature CD4+CD8+. Infected animals also exhibit enhanced levels of expression of both mRNA TNF-α receptors in the CD4+CD8+ subpopulation. Our findings suggest that in T. cruzi acute infection, when TNF-α is complexed with fibronectin, it favours the altered migration of thymocytes, promoting the release of mature and immature T cells to different compartments of the immune system. Conceptually, this work reinforces the notion that thymocyte migration is a multivectorial biological event in health and disease, and that TNF-α is a further player in the process.
References
[1]
Leite-de-Moraes MC, Hontebeyrie-Joskowicz M, Leboulenger F, Savino W, Dardenne M, et al. (1991) Studies on the thymus in Chagas' disease. II. Thymocyte subset fluctuations in Trypanosoma cruzi-infected mice: relationship to stress. Scand J Immunol 33: 267–275.
[2]
Roggero E, Pérez A, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, et al. (2002) Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin Exp Immunol 128: 421–8.
[3]
Pérez AR, Roggero E, Nicora A, Palazzi J, Besedovsky HO, et al. (2007) Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun 21: 890–900.
[4]
Cotta-de-Almeida V, Bonomo A, Mendes-da-Cruz DA, Riederer I, De Meis J, et al. (2003) Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration. Eur J Immunol 33: 2439–2448.
[5]
Mendes-da-Cruz DA, Silva JS, Cotta-de-Almeida V, Savino W (2006) Altered thymocyte migration during experimental acute Trypanosoma cruzi infection: combined role of fibronectin and the chemokines CXCL12 and CCL4. Eur J Immunol 36: 1486–1493.
[6]
Savino W, Villa-Verde DM, Mendes-da-Cruz DA, Silva-Monteiro E, Perez AR, et al. (2007) Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Cytokine Growth Factor Rev 18: 107–124.
[7]
Savino W, Leite-de-Moraes MC, Hontebeyrie-Joskowicz M, Dardenne M (1989) Studies on the thymus in Chagas' disease. I. Changes in the thymic microenvironment in mice acutely infected with Trypanosoma cruzi. Eur J Immunol 19: 1727–1733.
[8]
Casta？os-Velez E, Maerlan S, Osorio LM, Aberg F, Biberfeld P, et al. (1998) Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun 66: 2960–2968.
[9]
H？lscher C, Mohrs M, Dai WJ, Kohler G, Ryffel B, et al. (2000) Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun 68: 4075–4083.
[10]
Roggero E, Piazzon I, Nepomnaschy I, Perez A, Velikovsky A, et al. (2004) Thymocyte depletion during acute Trypanosoma cruzi infection in C57BL/6 mice is partly reverted by lipopolysaccharide pre-treatment. FEMS Immunol Med Microbiol 41: 123–131.
[11]
Lannes-Vieira J, Pereira IR, Vinagre NF, Arnez LE (2011) TNF-α and TNFR in Chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy. Adv Exp Med Biol 691: 221–230.
[12]
Roggero E, Pérez AR, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, et al. (2006) Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol 190: 495–503.
[13]
Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, et al. (2001) Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433–1440.
[14]
Kroll-Palhares K, Silvério JC, Silva AA, Michailowsky V, Marino AP, et al. (2008) TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade. Mem Inst Oswaldo Cruz 103: 375–385.
[15]
Savino W, Dalmau SR, De Almeida VC (2000) Role of extracellular matrix-mediated interactions in thymocyte migration. Dev Immunol 7: 279–291.
[16]
Savino W, Mendes-da-Cruz DA, Silva JS, Dardenne M, Cotta-de-Almeida V (2002) Intrathymic T-cell migration: a combinatorial interplay of extracellular matrix and chemokines? Trends Immunol 23: 305–313.
[17]
Norment AM, Bevan MJ (2000) Role of chemokines in thymocyte development. Semin Immunol 12: 445–455.
[18]
Allende ML, Dreier JL, Mandala S, Proia RL (2004) Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 279: 15396–15401.
[19]
Alfonso C, McHeyzer-Williams MG, Rosen H (2006) CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors. Eur J Immunol 36: 149–159.
Smaniotto S, de Mello-Coelho V, Villa-Verde DM, Pléau JM, Postel-Vinay MC, et al. (2005) Growth hormone modulates thymocyte development in vivo through a combined action of laminin and CXC chemokine ligand 12. Endocrinology 146: 3005–3017.
Alon R, Cahalon L, Hershkoviz R, Elbaz D, Reizis B, et al. (1994) TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J Immunol 152: 1304–1313.
[24]
Scollay RG, Butcher EC, Weissman IL (1980) Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol 10: 210–218.
[25]
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–8.
[26]
Savino W (2006) The thymus is a common target organ in infectious diseases. PLoS Pathog 2(6): e62.
[27]
Morrot A, Terra-Granado E, Pérez AR, Silva-Barbosa SS, Mili？evi？ NM, et al. (2011) Thymus atrophy during Trypanosoma cruzi infection does not affect thymocyte negative selection but results in the export of activated CD4+CD8+ T cells associated with severe clinical forms of human Chagas disease. Plos Neg Trop Dis 5(8): e1268.
[28]
Gresser I, Woodrow D, Moss J, Maury C, Tavernier J, et al. (1987) Toxics effects of recombinant tumor necrosis factor in sucking mice. Comparisons with interferon α/β. Am J Pathol 128: 8–13.
[29]
Probert L, Keffer J, Corbella P, Cazlaris H, Patsavoudi E, et al. (1993) Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell targeted human tumor necrosis factors transgenes. J Immunol 151: 1894–1906.
[30]
Chen W, Kuolee R, Austin JW, Shen H, Che Y, et al. (2005) Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion. Microb Pathog 39: 189–196.
[31]
Pérez AR, Silva-Barbosa SD, Berbert LR, Revelli S, Beloscar J, et al. (2011) Immunoneuroendocrine alterations in patients with progressive forms of chronic Chagas disease. J Neuroimmunol 235: 84–90.
[32]
Rivera MT, Marques-de-Araujo S, Lucas R, Deman J, Truyens C, et al. (1995) High tumor necrosis factor alpha (TNF-alpha) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-alpha gene transcription in their offspring. Infect Immun 63: 591–595.
[33]
Mucci J, Mocetti E, Leguizamón MS, Campetella O (2005) A sexual dimorphism in intrathymic sialylation survey is revealed by the trans-sialidase from Trypanosoma cruzi. J Immunol 174: 4545–4550.
[34]
Vaday GG, Franitza S, Schor H, Hecht I, Brill A, et al. (2001) Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol 69: 885–892.
[35]
Mendes-da-Cruz DA, Smaniotto S, Keller AC, Dardenne M, Savino W (2008) Multivectorial abnormal cell migration in the NOD mouse thymus. J Immunol 180: 4639–4647.
[36]
Wang B, Kondo S, Shivji GM, Fujisawa H, Mak TW, et al. (1996) Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunol 88: 284–8.
[37]
Corredor J, Yan F, Shen CC, Tong W, John SK, et al. (2003) Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am J Physiol Cell Physiol 284: C953–61.
[38]
Tarleton RL, Sun J, Zhang L, Postan M (1994) Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun 62: 1820–1829.
[39]
Silva-Barbosa SD, Savino W (2000) The involvement of laminin in anti-myocardial cell autoimmune response in murine Chagas disease. Dev Immunol 7: 293–301.
[40]
Mendes-da-Cruz DA, de Meis J, Cotta-de-Almeida V, Savino W (2003) Experimental Trypanosoma cruzi infection alters the shaping of the central and peripheral T-cell repertoire. Microbes Infect 5: 825–32.
